Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00360022 · ClinicalTrials.gov registry record · NA

Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)

A NA study, sponsored by Vanderbilt University Medical Center.

Terminated
Registry status
NA
Development phase
28
Enrollment target

NCT00360022: Clinical Trial NA study, sponsored by Vanderbilt University Medical Center.

NCT00360022 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00360022, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.

TERMINATED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this study is to determine if the program that has been made to ease the transition of care for adolescent patients with IBD from pediatric gastroenterology to adult gastroenterology is effective to reduce the risk of disease flare during this period. Patient satisfaction with this program will also be assessed.

Interventions

  • OTHER Joint visits

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2006-08
Est. Completion 2011-02
Phase NA

Why NCT00360022 stopped before completion

NCT00360022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Joint visits is the first listed.

NCT00360022 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00360022 about?

NCT00360022 is a clinical study titled "Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI)". The purpose of this study is to determine if the program that has been made to ease the transition of care for adolescent patients with IBD from pediatric gastroenterology to adult gastroenterology is effective to reduce the risk of disease flare during this period. Patient satisfaction with this pr...

What is the current status of trial NCT00360022?

This trial is currently terminated. It is a NA study. The enrollment target is 28 participants. The study started on 2006-08. Estimated completion is 2011-02.

What interventions are being tested in trial NCT00360022?

The interventions under investigation include: Joint visits (OTHER).

Who is sponsoring clinical trial NCT00360022?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00360022's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00360022, the US trial registry maintained by the National Library of Medicine. NCT00360022 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.